Lumenis Moses 2.0 Holmium Laser

Description

Lumenis Moses 2.0 Holmium Laser

Lumenis Moses 2.0 Holmium Laser represents the latest in laser technology for stone management. Its unique holmium technology splits the laser beam into two pulses: one to create a vapor bubble and the second to deliver the laser energy directly to the stone. This technique results in more efficient stone fragmentation and dusting, significantly reducing the time required for procedures and improving patient outcomes.

The precision of the Moses 2.0 machine ensures that urologists can target stones with exceptional accuracy, minimizing damage to surrounding tissues. This is particularly beneficial in complex cases where stones are located in hard-to-reach areas. The reduced retropulsion, where fragments are pushed away from the laser, leads to fewer secondary procedures and a higher success rate in completely clearing stones.

Treating Kidney Stones:

Kidney stones are one of the most common urological problems in the United States and are also known as Renal Calculi. Approximately 1 in 11 people in the U.S. are affected by kidney stones. The stones grow slowly in the affected patients (over several years) and do not usually cause pain until they move or obstruct the kidney.

With medical treatment more than half of these stones will pass on their own, usually within 1 to 2 weeks. However, stones that become lodged in the ureter or larger stones may require surgical removal.

The Holmium laser has significantly improved the management of stones, providing a less invasive and more effective treatment. Holmium lasers and associated fibers effectively fragment stones of any composition or size throughout the urinary tract.

MOSES Technology
A patent-protected innovation revolutionizing urology care.

Nearly 20% reduction in procedure time
As shown in a randomized clinical trial, compared with regular Holmium pulse, MOSES Technology reduces lithotripsy procedure time by nearly 20%, making your treatments more efficient.

50% reduction in retropulsion
Displayed 50% reduction in retropulsion compared to regular Holmium pulse, potentially minimizing incidents of ureteral stone migration into the kidney and avoiding stone chasing.

33% reduction in fragmentation time
MOSES Technology optimized energy transmission makes every shot count, reducing your fragmentation time by 33%.

For BPH results in over 90% of patients being discharged on the same-day
Same-day catheter removal is feasible in select patients after HoLEP. A study demonstrates 90% success of same-day catheter removal after using MOSES Technology.